Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

122 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Not yet recruiting

Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax

NCT07691047

Conditions: Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Clinique de l'Europe Amiens, France

Hôpital Privé du Confluent Nantes, France

View Trial Details

Not yet recruiting

Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).

NCT07624799

Conditions: CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

U96-CAR-T-Cells For R/R B-ALL

NCT07511426

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not yet recruiting

Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms

NCT07337967

Conditions: B Chronic Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

NCT07166549

Conditions: B Cell Lymphoma, B Cell Malignancies, B-cell Leukemia, +25 more
Locations: University Hospital Basel, Division of Hematology or Medical Oncology Basel, Canton of Basel-City, Switzerland

View Trial Details

Not yet recruiting

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

NCT06979076

Conditions: CLL (Chronic Lymphocytic Leukemia), Chronic Disease, Disease Attributes, +15 more
Locations: Not specified

View Trial Details

Not yet recruiting

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

NCT05779930

Conditions: Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B Cell Leukemia, +22 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Not yet recruiting

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

NCT07113132

Conditions: Acute Lymphoblastic Leukemia ALL, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +16 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

NCT02473757

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

NCT05589896

Conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
Locations: City of Hope Duarte, California, United States

Moffitt Cancer Center Tampa, Florida, United States

Emory University - Winship Cancer Institute Atlanta, Georgia, United States

Henry Ford Cancer Institute Detroit, Michigan, United States

View Trial Details

Leukemia, B-Cell

Leukemia, B-Cell trial results

Related conditions